NLRP3 and diabetic kidney disease: However, the in-vitro results presented in the study do help define that AS-IV reduced inflammatory reaction in PA-induced HK-2 cells, and CD36-ROS-NLRP3 signaling is probably a new mechanism central to renal tubular protection in DKD.